Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 19 (116th)

Lower Costs, More Cures Act of 2019

referredUnited States· United States Congress· EN

Introduced

9 December 2019

Last action

19 December 2019 · Referred

Status

Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

Sponsors

Rep. Walden, Greg [R-OR-2], Rep. Brady, Kevin [R-TX-8], Rep. Foxx, Virginia [R-NC-5], Rep. Collins, Doug [R-GA-9], Rep. Burgess, Michael C. [R-TX-26], Rep. Nunes, Devin [R-CA-22], Rep. Walberg, Tim [R-MI-5], Rep. Sensenbrenner, F. James, Jr. [R-WI-5], Rep. Scalise, Steve [R-LA-1], Rep. Cheney, Liz [R-WY-At Large], Rep. Upton, Fred [R-MI-6], Rep. Shimkus, John [R-IL-15], Rep. Latta, Robert E. [R-OH-5], Rep. Guthrie, Brett [R-KY-2], Rep. McMorris Rodgers, Cathy [R-WA-5], Rep. Olson, Pete [R-TX-22], Rep. McKinley, David B. [R-WV-1], Rep. Kinzinger, Adam [R-IL-16], Rep. Griffith, H. Morgan [R-VA-9], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Johnson, Bill [R-OH-6], Rep. Long, Billy [R-MO-7], Rep. Bucshon, Larry [R-IN-8], Rep. Flores, Bill [R-TX-17], Rep. Brooks, Susan W. [R-IN-5], Sen. Mullin, Markwayne [R-OK], Rep. Hudson, Richard [R-NC-8], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Gianforte, Greg [R-MT-At Large], Rep. Palmer, Gary J. [R-AL-6], Rep. Cole, Tom [R-OK-4], Rep. Williams, Roger [R-TX-25], Rep. Abraham, Ralph Lee [R-LA-5], Rep. Keller, Fred [R-PA-12], Rep. Rutherford, John H. [R-FL-5], Rep. Ferguson, A. Drew, IV [R-GA-3], Rep. Kustoff, David [R-TN-8], Denver Riggleman, Rep. Westerman, Bruce [R-AR-4], Rep. Graves, Garret [R-LA-6], Rep. LaMalfa, Doug [R-CA-1], Rep. Baird, James R. [R-IN-4], Rep. Huizenga, Bill [R-MI-4], Rep. Murphy, Gregory F. [R-NC-3], Rep. Conaway, K. Michael [R-TX-11], Rep. Allen, Rick W. [R-GA-12], Rep. Weber, Randy K. Sr. [R-TX-14], Rep. Newhouse, Dan [R-WA-4]

Subjects

Healthcare

Source updated

7 April 2025

Healthcare

Summary

Lower Costs, More Cures Act of 2019 This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs. The bill generally limits payment amounts for drugs and biologics under Medicare medical services, reduces cost-sharing under the Medicare prescription drug benefit, modifies certain authorities and requirements under the Medicaid Drug Rebate Program, revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and establishes several reporting requirements for drug manufacturers with respect to drug prices.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 9 December 2019

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 9 December 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 9 December 2019

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 10 December 2019

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 19 December 2019

    Referred

    Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 9 December 2019

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 9 December 2019

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 9 December 2019

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 151 sponsors and actors.

Related records

Showing 8 of 34 related records.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.